PAOG Advances RespRx Research Into International CBD Pharma Research Arena

Sandusky, OH – Sep 15, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today announced an international research initiative to advance its hemp-derived cannabidiol (CBD) pharmaceutical treatment for Chronic Obstructive Pulmonary Disease (COPD). The COPD treatment, RespRx, is derived from a patented cannabis extraction method – U.S. Patent No. 9,199,960 entitled

ALYI EV Battery Strategy Keeps Pace With “It’s All About The Batteries” Outlook

Dallas, TX – September 10, 2020 – OTC PR WIRE – Alternet Systems, Inc. (OTC PINK: ALYI) today highlighted an article in Barron’s featuring an electric vehicle (EV) battery technology backed by Bill Gates and Tesla co-founder, J.B. Straubel. The article characterizes the essential role of advancing battery technology to the ultimate widespread adoption of

DGDM Provides Corporate Update as Post-COVID-19 Business and Opportunities Come Into View

FLOWER MOUND, TX, August 20, 2020 — OTC PR WIRE — Digital Development Partners, Inc. (OTC PINK: DGDM) (which will become Black Bird Potentials Inc.), manufacturer of Grizzly Creek Naturals CBD products, provided a post-COVID-19 corporate overview and business update. Forward from COVID-19. “Our company has emerged from the COVID-19 situation a stronger company,” said

Baristas Munchie Magic Doubles Locations Over Past 30 Days From 12 to 24 Delivering Ben & Jerry’s and Snacks to Customers

Seattle WA, August 13, 2020 – OTC PR WIRE –  Baristas Coffee Company/Munchie Magic (OTC PINK: BCCI) has doubled its locations over the past 30 days bringing the total locations open from 12 to 24. Munchie Magic had previously opened 12 locations since Washington State issued a statewide stay at home order on March 23rd,

PAOG CEO Interview: Cannabis Pharmaceutical Development; Acquired Revenue; Updated Financials; Why PPS Is Undervalued And Timing Of Anticipated Correction

Sandusky, OH – Aug 7, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today announced an interview of CEO James C. DiPrima on MoneyTV with Donald Baillargeon.  The interview is available on the MoneyTV website discussing new cannabis pharmaceutical developments, a recently acquired revenue stream, upcoming financial reports bringing the company

Contact Us

  • 707-OTC-WIRE (707-682-9473)
  • cs@otcprwire.com

All Rights Reserved © 2019